These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 15466911

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S, Zhang L, Wang H, Yi Z, Li L, Gao L, Zhao J, Tisch R, Katz JD, Wang B.
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [Abstract] [Full Text] [Related]

  • 23. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice.
    DiLorenzo TP, Serreze DV.
    Immunol Rev; 2005 Apr; 204():250-63. PubMed ID: 15790363
    [Abstract] [Full Text] [Related]

  • 24. Cytotoxic T-lymphocyte-mediated killing of human pancreatic islet cells in vitro.
    Campbell PD, Estella E, Dudek NL, Jhala G, Thomas HE, Kay TW, Mannering SI.
    Hum Immunol; 2008 Sep; 69(9):543-51. PubMed ID: 18639598
    [Abstract] [Full Text] [Related]

  • 25. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
    Shieh SJ, Chou FC, Yu PN, Lin WC, Chang DM, Roffler SR, Sytwu HK.
    J Immunol; 2009 Aug 15; 183(4):2277-85. PubMed ID: 19635924
    [Abstract] [Full Text] [Related]

  • 26. On the pathogenicity of autoantigen-specific T-cell receptors.
    Burton AR, Vincent E, Arnold PY, Lennon GP, Smeltzer M, Li CS, Haskins K, Hutton J, Tisch RM, Sercarz EE, Santamaria P, Workman CJ, Vignali DA.
    Diabetes; 2008 May 15; 57(5):1321-30. PubMed ID: 18299317
    [Abstract] [Full Text] [Related]

  • 27. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
    Li L, He Q, Garland A, Yi Z, Aybar LT, Kepler TB, Frelinger JA, Wang B, Tisch R.
    J Immunol; 2009 Dec 01; 183(11):7585-91. PubMed ID: 19917704
    [Abstract] [Full Text] [Related]

  • 28. Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus.
    Liadis N, Murakami K, Eweida M, Elford AR, Sheu L, Gaisano HY, Hakem R, Ohashi PS, Woo M.
    Mol Cell Biol; 2005 May 01; 25(9):3620-9. PubMed ID: 15831467
    [Abstract] [Full Text] [Related]

  • 29. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans.
    Wang H, Li Y, Sun Q, Yang G.
    Chin Med J (Engl); 2000 May 01; 113(5):433-6. PubMed ID: 11776099
    [Abstract] [Full Text] [Related]

  • 30. Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice.
    Suarez-Pinzon WL, Power RF, Rabinovitch A.
    Diabetologia; 2000 Sep 01; 43(9):1149-56. PubMed ID: 11043861
    [Abstract] [Full Text] [Related]

  • 31. Intra-islet proliferation of cytotoxic T lymphocytes contributes to insulitis progression.
    Graham KL, Krishnamurthy B, Fynch S, Ayala-Perez R, Slattery RM, Santamaria P, Thomas HE, Kay TW.
    Eur J Immunol; 2012 Jul 01; 42(7):1717-22. PubMed ID: 22585671
    [Abstract] [Full Text] [Related]

  • 32. Molecular mechanisms of pancreatic beta-cell destruction in autoimmune diabetes: potential targets for preventive therapy.
    Iwahashi H, Itoh N, Yamagata K, Imagawa A, Nakajima H, Tomita K, Moriwaki M, Waguri M, Yamamoto K, Miyagawa J, Namba M, Hanafusa T, Matsuzawa Y.
    Cytokines Cell Mol Ther; 1998 Mar 01; 4(1):45-51. PubMed ID: 9557216
    [Abstract] [Full Text] [Related]

  • 33. Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin.
    Jin Y, Qu A, Wang GM, Hao J, Gao X, Xie S.
    Gene Ther; 2004 Jun 01; 11(12):982-91. PubMed ID: 15042121
    [Abstract] [Full Text] [Related]

  • 34. Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes.
    Apostolou I, Hao Z, Rajewsky K, von Boehmer H.
    J Exp Med; 2003 Oct 06; 198(7):1103-6. PubMed ID: 14530378
    [Abstract] [Full Text] [Related]

  • 35. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.
    de Jersey J, Snelgrove SL, Palmer SE, Teteris SA, Mullbacher A, Miller JF, Slattery RM.
    Proc Natl Acad Sci U S A; 2007 Jan 23; 104(4):1295-300. PubMed ID: 17229843
    [Abstract] [Full Text] [Related]

  • 36. Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration.
    Horwitz MS, Fine C, Ilic A, Sarvetnick N.
    J Autoimmun; 2001 May 23; 16(3):211-7. PubMed ID: 11334485
    [Abstract] [Full Text] [Related]

  • 37. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes.
    Han B, Serra P, Yamanouchi J, Amrani A, Elliott JF, Dickie P, Dilorenzo TP, Santamaria P.
    J Clin Invest; 2005 Jul 23; 115(7):1879-87. PubMed ID: 15937548
    [Abstract] [Full Text] [Related]

  • 38. Adenoviral-mediated overexpression of membrane-bound human FasL and human decoy Fas protect pig islets against human CD8+ CTL-mediated cytotoxicity.
    Kawamoto K, Tanemura M, Komoda H, Omori T, Fumimoto Y, Shimada K, Deguchi T, Saga A, Kakuda A, Nishida T, Sawa Y, Ito T.
    Transplant Proc; 2006 Dec 23; 38(10):3286-8. PubMed ID: 17175251
    [Abstract] [Full Text] [Related]

  • 39. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
    Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V.
    Ann N Y Acad Sci; 2005 Jun 23; 1051():72-87. PubMed ID: 16126946
    [Abstract] [Full Text] [Related]

  • 40. In vivo cytotoxicity of insulin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice.
    Jarchum I, Baker JC, Yamada T, Takaki T, Marron MP, Serreze DV, DiLorenzo TP.
    Diabetes; 2007 Oct 23; 56(10):2551-60. PubMed ID: 17620420
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.